Edition:
United States

PolarityTE Inc (COOL.OQ)

COOL.OQ on NASDAQ Stock Exchange Capital Market

26.58USD
10:51am EDT
Change (% chg)

$1.50 (+5.98%)
Prev Close
$25.08
Open
$24.87
Day's High
$26.58
Day's Low
$24.87
Volume
10,307
Avg. Vol
57,616
52-wk High
$32.63
52-wk Low
$14.90

Chart for

About

PolarityTE, Inc., formerly Majesco Entertainment Company, is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. The Company seeks to develop and obtain regulatory approval for... (more)

Overall

Beta: 1.01
Market Cap(Mil.): $463.70
Shares Outstanding(Mil.): 18.49
Dividend: --
Yield (%): --

Financials

  COOL.OQ Industry Sector
P/E (TTM): -- 33.67 11.54
EPS (TTM): -27.35 -- --
ROI: -3,354.36 16.25 18.35
ROE: -- 21.20 19.73

BRIEF-PolarityTE Acquires Operating GLP/USDA Preclinical Biomedical Research Facility

* POLARITYTE ACQUIRES OPERATING GLP/USDA PRECLINICAL BIOMEDICAL RESEARCH FACILITY AND ANNOUNCES CAROLINE GARRETT DVM FROM JOHNS HOPKINS AS CHIEF VETERINARY OFFICER AT POLARITY Source text for Eikon: Further company coverage:

May 14 2018

BRIEF-Polarityte Regains Compliance With Nasdaq Independent Director Requirement

* POLARITYTE, INC. REGAINS COMPLIANCE WITH NASDAQ INDEPENDENT DIRECTOR REQUIREMENT Source text for Eikon: Further company coverage:

Apr 25 2018

BRIEF-PolarityTE Says Public Offering Of 2.03 Mln Common Shares Priced At $16 Per Share

* POLARITYTE ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

Apr 12 2018

BRIEF-PolarityTE Announces Public Offering Of Common Stock

* POLARITYTE - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR R&D OF ITS PRODUCTS AND PRODUCT CANDIDATES Source text for Eikon: Further company coverage:

Apr 11 2018

BRIEF-John Stetson Reports 7.7 Pct Stake In PolarityTE

* JOHN STETSON REPORTS A 7.7 PERCENT STAKE IN POLARITYTE, INC AS OF FEBRUARY 12 - SEC FILING Source text: (http://bit.ly/2suMAUl) Further company coverage:

Feb 13 2018

BRIEF-Polarityte Inc Files For Non-Timely 10-K

* POLARITYTE INC FILES FOR NON-TIMELY 10-K - SEC FILING Source text : (http://bit.ly/2Ftie6i) Further company coverage:

Jan 30 2018

BRIEF-Polarityte Says Human Use Of Skinte Is Underway

* POLARITYTE INC - RESULTS AND OUTCOMES FROM FIRST GROUP OF SKINTE TREATED PATIENTS ARE EXPECTED TO BE PUBLISHED THROUGHOUT FIRST HALF 2018 Source text for Eikon: Further company coverage:

Dec 15 2017

Earnings vs. Estimates